LA THERAPIE CIBLEE EN ONCOLOGIE : CANCER DU SEIN
| dc.contributor.advisor | EL Mustafa El Fahime | |
| dc.contributor.author | Meryem Chennaq | |
| dc.date.accessioned | 2023-09-15T13:42:48Z | |
| dc.date.accessioned | 2026-01-22T13:34:41Z | |
| dc.date.available | 2023-09-15T13:42:48Z | |
| dc.date.issued | 2023 | |
| dc.description.collaborator | EL Mustafa El Fahime | |
| dc.description.collaborator | Yahia Cherrah | |
| dc.description.collaborator | Younes Rahali | |
| dc.description.collaborator | Jaouad El Harti | |
| dc.description.collaborator | Rachid El Jaoudi | |
| dc.identifier.uri | https://toubkalpreprod.imist.ma/handle/123456789/19321 | |
| dc.language.iso | fr | |
| dc.publisher | Université Mohammed 5 de Rabat, Faculté de Médecine et de Pharmacie, Rabat | fr_FR |
| dc.subject | Cancer du sein; Thérapies ciblées; Voies de signalisation; Anticorps monoclonaux | fr_FR |
| dc.subject.other | Sciences médicales | |
| dc.subject.specific | Oncologie | |
| dc.title | LA THERAPIE CIBLEE EN ONCOLOGIE : CANCER DU SEIN | fr_FR |
Files
Original bundle
1 - 1 of 1